The Asuragen Oncology portfolio uses our proprietary molecular chemistry and informatics solutions to deliver critical clinical research insights that drive the evolution of therapy, patient monitoring and precision medicine.
The QuantideX® suite of products employs molecular methods ranging from qPCR to NGS to help advance our understanding of cancer. Our approach is to selectively deploy the right technology for the right result.
Asuragen focuses on solving three key areas of customer need:
Informatics solutions that simplify assay data management, enhance analytics and reduce risk of manual-read errors
All-inclusive kits that optimize efficiency, reduce hands-on time and minimize cost
“Push-button”, Sample-Aware™ informatics and built-in quality checks that minimize risk of erroneous results and assay failures